Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Globe Life
GL
$14.2B
| $16.5M | 0.02% |
318,135
+139,666
| +78% | +$6.97M |
|
877
Wheaton Precious Metals
WPM
$49.5B
| $16.5M | 0.02% |
826,130
+401,938
| +95% | +$8.73M |
|
878
Everest Group
EG
$14.5B
| $16.5M | 0.02% |
+106,547
| New | +$16.3M |
|
879
Ralph Lauren
RL
$22.6B
| $16.5M | 0.02% |
93,755
-51,016
| -35% | -$8.69M |
|
|
MWV
880
DELISTED
MEADWESTVACO CORP
MWV
| $16.5M | 0.02% |
457,331
+194,620
| +74% | +$7.02M |
|
881
Analog Devices
ADI
$179B
| $16.4M | 0.02% |
328,766
+38,720
| +13% | +$1.89M |
|
882
PUT
Bristol-Myers Squibb
BMY
$133B
| $16.4M | 0.02% |
310,100
-21,800
| -7% | -$1.11M |
|
883
Equity Lifestyle Properties
ELS
$12.6B
| $16.4M | 0.02% |
912,704
+445,046
| +95% | +$8.05M |
|
884
PUT
VanEck Oil Services ETF
OIH
$2.06B
| $16.4M | 0.02% |
17,085
+230
| +1% | +$224K |
|
|
MKTG
885
DELISTED
RESPONSYS INC COM STK (CA)
MKTG
| $16.4M | 0.02% |
606,086
+597,255
| +6,763% | +$10.9M |
|
886
Oneok
OKE
$57.2B
| $16.3M | 0.02% |
301,176
-62,130
| -17% | -$3.11M |
|
887
HCA Healthcare
HCA
$87.2B
| $16.3M | 0.02% |
347,691
-27,023
| -7% | -$1.25M |
|
|
888
CALL
Oneok
OKE
$57.2B
| $16.3M | 0.02% |
300,513
+41,805
| +16% | +$2.1M |
|
889
CALL
Wolfspeed
WOLF
$1.23B
| $16.3M | 0.02% |
263,000
-19,600
| -7% | -$1.21M |
|
890
CubeSmart
CUBE
$9.39B
| $16.3M | 0.02% |
1,086,990
+477,146
| +78% | +$8.19M |
|
891
Lam Research
LRCX
$367B
| $16.2M | 0.02% |
3,004,850
+1,535,360
| +104% | +$8.08M |
|
892
PUT
Nike
NKE
$61.9B
| $16.2M | 0.02% |
415,200
-105,200
| -20% | -$4.03M |
|
893
Northern Trust
NTRS
$33.3B
| $16.2M | 0.02% |
265,094
-10,904
| -4% | -$625K |
|
894
Meritage Homes
MTH
$4.58B
| $16.2M | 0.02% |
687,500
+641,594
| +1,398% | +$13.9M |
|
895
Monster Beverage
MNST
$94.3B
| $16.1M | 0.02% |
1,443,630
-62,568
| -4% | -$615K |
|
896
PUT
Abercrombie & Fitch
ANF
$4.42B
| $16.1M | 0.02% |
503,300
+326,600
| +185% | +$11.3M |
|
897
CALL
General Dynamics
GD
$104B
| $16.1M | 0.02% |
169,400
+6,900
| +4% | +$616K |
|
|
B
898
PUT
Barrick Mining
B
$61.5B
| $16.1M | 0.02% |
945,700
-30,400
| -3% | -$536K |
|
899
PUT
Deere & Co
DE
$160B
| $16M | 0.02% |
175,900
-52,900
| -23% | -$4.48M |
|
900
PVH
PVH
$4B
| $15.9M | 0.02% |
117,167
+5,548
| +5% | +$706K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.